Statistics for Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant
Total visits
views | |
---|---|
Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant | 85 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
PO.19.00258.pdf | 222 |
Top country views
views | |
---|---|
United States | 68 |
Canada | 2 |
China | 1 |
Germany | 1 |
Malaysia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 41 |
Fairfield | 9 |
Chicago | 4 |
Cambridge | 2 |
Houston | 2 |
Toronto | 2 |
Ann Arbor | 1 |
Baltimore | 1 |
Beijing | 1 |
Indianapolis | 1 |
Kiez | 1 |
San Francisco | 1 |
Seremban | 1 |
Stockholm | 1 |
White Plains | 1 |